Publications by authors named "N Lavi"

Claim this Profile
I
Impact of skull base cisterns invasion and extent of resection on the management of skull base intracranial epidermoid tumors.
Samuel Moscovici, Nir Lavi, Andrew H Kaye, Carlos Candanedo, José E Cohen

J Clin Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1.
Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, Brea Lipe, Noa Lavi

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm.
Michal Nordkin, Nashwa Fadaos, Ronit Leiba, Nurit Sharon-Horesh, Ben Varon, Noa Lavi

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Needs of Patients with Multiple Myeloma: A Questionnaire-Based Study in Israeli Patients.
Ilana Levy Yurkovski, Shira Ben-Dov, Varda Shoam, Micha Yuz, Noa Lavi

Acta Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.
Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, Ronit Leiba, Nurit Sharon-Horesh, Noa Lavi

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis